GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alk-Abello AS (LTS:0OIR) » Definitions » Median PS Value

Alk-Abello AS (LTS:0OIR) Median PS Value : kr109.08 (As of Dec. 15, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Alk-Abello AS Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Alk-Abello AS's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was kr24.442. Alk-Abello AS's 10-Year median PS Ratio is 4.4628. Therefore, the Median PS Value for today is kr109.08.

As of today (2024-12-15), Alk-Abello AS's share price is kr149.45. Alk-Abello AS's Median PS Value is kr109.08. Therefore, Alk-Abello AS's Price to Median PS Value for today is 1.37.

The historical rank and industry rank for Alk-Abello AS's Median PS Value or its related term are showing as below:

LTS:0OIR' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.97   Med: 1.7   Max: 2.78
Current: 1.37

During the past 13 years, the highest Price to Median PS Value of Alk-Abello AS was 2.78. The lowest was 0.97. And the median was 1.70.

LTS:0OIR's Price-to-Median-PS-Value is ranked worse than
82.2% of 264 companies
in the Biotechnology industry
Industry Median: 0.7 vs LTS:0OIR: 1.37

Alk-Abello AS Median PS Value Historical Data

The historical data trend for Alk-Abello AS's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alk-Abello AS Median PS Value Chart

Alk-Abello AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45.55 50.81 61.88 113.52 128.69

Alk-Abello AS Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 154.75 128.69 111.64 97.48 97.20

Competitive Comparison of Alk-Abello AS's Median PS Value

For the Biotechnology subindustry, Alk-Abello AS's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alk-Abello AS's Price-to-Median-PS-Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alk-Abello AS's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Alk-Abello AS's Price-to-Median-PS-Value falls into.



Alk-Abello AS Median PS Value Calculation

Alk-Abello AS's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=24.442*4.4628
=109.08

10-Year Median PS Ratio is 4.4628.
Alk-Abello AS's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr24.442.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alk-Abello AS  (LTS:0OIR) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Alk-Abello AS's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=149.45/109.08
=1.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alk-Abello AS Median PS Value Related Terms

Thank you for viewing the detailed overview of Alk-Abello AS's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Alk-Abello AS Business Description

Traded in Other Exchanges
Address
Boge Alle 6-8, Horsholm, DNK, DK-2970
Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication. The company operates in Europe, North America and International Markets. It derives maximum revenue from Europe.

Alk-Abello AS Headlines

No Headlines